Maternal Thyroid Hormones in Early Pregnancy and Risk of Breech Presentation

Journal of Obstetrics and Gynaecology Canada

Volumn 32, Issue 10, 2010, Pages 948-955

  Salehidobakhshari, Mehrnaz ^a   Bamforth, Fiona ^a   Burstyn, Igor ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DREXEL UNIVERSITY   (United States)

Author keywords

Breech; Case control study; Fetus; Free thyroxine; Thyrotrophin

Indexed keywords

THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BIRTH WEIGHT; BREECH PRESENTATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HORMONE ACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; PREGNANCY OUTCOME; RISK ASSESSMENT; THYROID HORMONE BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; PREGNANCY; RISK; RISK FACTOR; STATISTICAL MODEL;

ADULT; BREECH PRESENTATION; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; PREGNANCY; RISK FACTORS; THYROID HORMONES; THYROTROPIN; THYROXINE;

EID: 79952201715     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34682-5     Document Type: Article

References (22)

1. Cunningham F.G., Gan N.F., Leveno K.J., Gilstrap L.C., Hauth J.C., Wenstrom K.D. Breech presentation and delivery. Williams Obstetrics 2009, 509-535. McGraw Hill, New York. 23rd ed. F.G. Cunningham, K.J. Leveno, S.L. Bloom, J.C. Hauth, D.J. Rouse, C.Y. Spong (Eds.).
2. Alberta Perinatal Health Program (APHP) Provincial Perinatal Report 2000-2004 Reprinted August 2006 Abridged Version [Internet]. Available at: . Accessed June 22, 2010. http://www.aphp.ca/pdf/AB%20PN%20Provincial%20Report%202000-2004%20final%20Abridged%20Version.pdf.
3. Talas B.B., Altinkaya S.O., Talas H., Danisman N., Gungor T. Predictive factors and short-term fetal outcomes of breech presentation: a case control study. Taiwan J Obstet Gynecol 2008, 47:402-407.
4. Villar J., Valladares E., Wojdyla D., Zavaleta N., Carroli G., Velazco A. Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet 2006, 367(9525):1819-1829.
5. Allen V.M., O'Connell C.M., Baskett T.F. Cumulative economic implications of initial method of delivery. Obstet Gynecol 2006, 108(3 Pt 1):549-555.
6. Nordtveit T.I., Melve K.K., Albrechtsen S., Skjaerven R. Maternal and paternal contribution to intergenerational recurrence of breech delivery: population based cohort study. BMJ 2008, 336(7649):872-876.
7. Rayl J., Gibson P.J., Hickok D.E. A population-based case-control study of risk factors for breech presentation. Am J Obstet Gynecol 1996, 174:28-32.
8. Pop V.J., Brouwers E.P., Wijnen H., Oei G., Essed G.G., Vader H.L. Low concentrations of maternal thyroxin during early gestation: a risk factor of breech presentation?. BJOG 2004, 111:925-930.
9. Pop V.J., Kuijpens J.L., van Baar A.L., Verkerk G., van Son M.M., de Vijlder J.J., et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol 1999, 50:149-155.
10. Pop V.J., Brouwers E.P., Vader H.L., Vulsma T., van Baar A.L., de Vijlder J.J. Maternal hypothyroxinemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol 2003, 59:282-288.
11. Forrest D. The developing brain and maternal thyroid hormone: finding the links. Endocrinology 2004, 145:4034.
12. Poole C. Low P-values or narrow confidence intervals: which are more durable?. Epidemiology 2001, 12:291-294.
13. Kuppens S.M., Kooistra L., Wijnen H.A., Crawford S., Vader H.L., Hasaart T.H., et al. Maternal thyroid function during gestation is related to breech presentation at term. Clin Endocrinol 2009, (Oxf) 2009 Oct 15; [Epub ahead of print]. 10.1111/j.1365-2265.2009.03729.x.
14. Männistö T., Vääräsmäki M., Pouta A., Hartikainen A.L., Ruokonen A., Surcel H.M., et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab 2009, 94(3):772-779.
15. Lee R.H., Spencer C.A., Mestman J.H., Miller E.A., Petrovic I., Braverman L.E., et al. Free T4 immunoassays are flawed during pregnancy. Obstet Gynecol 2009, 200(3):260.1-6.
16. Casey B.M., Leveno K.J. Thyroid disease in pregnancy. Obstet Gynecol 2006, 108:1283-1292.
17. Kooistra L., Crawford S., van Baar A.L., Brouwers E.P., Pop V.J. Neonatal effects of maternal hypothyroxinemia during early pregnancy. Pediatrics 2006, 117:161-167.
18. Casey B.M., Dashe J.S., Spong C.Y., McIntire D.D., Leveno K.J., Cunningham G.F. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol 2007, 109:1129-1135.
19. Cleary-Goldman J., Malone F.D., Lambert-Messerlian G., Sullivan L., Canick J., Porter T.F., et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 2008, 112:85-92.
20. Hamm M.P., Cherry N.M., Martin J.W., Bamforth F., Burstyn I. The impact of isolated maternal hypothyroxinemia on perinatal morbidity. J Obstet Gynaecol Can 2009, 31:1015-1021.
21. Casey B.M., Dashe J.S., Wells C.E., McIntire D.D., Byrd W., Leveno K.J., et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005, 105:239-245.
22. Wijnen H.A., Kooistra L., Vader H.L., Essed G.G., Mol B.W., Pop V.J. Maternal thyroid hormone concentration during late gestation is associated with foetal position at birth. Clin Endocrinol 2009, 71(5):746-751.